StreetInsider.com News Articles

Form 8-K Senseonics Holdings, For: Jun 01

Mon, 08 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260608/26617279.html

Form 8-K Senseonics Holdings, For: Jun 01

Mon, 08 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260608/26617279.html

Senseonics presents real-world data on Eversense 365 CGM at ADA meeting

Mon, 08 Jun 2026 02:56:33 -0400

Senseonics Holdings Inc. (NASDAQ: SENS) presented real-world evidence data on its Eversense 365 continuous glucose monitoring system at the American Diabetes Association's Scientific Sessions in New Orleans on June 5-8.

The study analyzed 12,360 Eversense 365 CGM sensors among open-loop users and 153 closed-loop users who used the system with the twiist Automated Insulin Delivery system for more than 30 days. The data expands on findings previously shared at the International Conference on Advanced Technologies & Treatments for Diabetes earlier this year.

Results showed an average transmitter wear time of 93.19% across all sensors. Users achieved a mean Glucose Management Indicator of

Senseonics presents real-world data on Eversense 365 CGM at ADA meeting

Mon, 08 Jun 2026 02:56:33 -0400

Results showed an average transmitter wear time of 93.19% across all sensors. Users achieved a mean Glucose Management Indicator of

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems

Sat, 06 Jun 2026 17:00:00 -0400

Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s differentiated approach and high performance

New data expands on findings shared at ATTD and reinforces Eversense 365’s strong patient adherence, glucometrics and hypoglycemic outcomes across an entire year

GERMANTOWN, Md., June 06, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable Continuous Glucose Monitoring (CGM) Systems for people with diabetes, today announces further data from a large real-world evidence study which reveals

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems

Sat, 06 Jun 2026 17:00:00 -0400

Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s differentiated approach and high performance

New data expands on findings shared at ATTD and reinforces Eversense 365’s strong patient adherence, glucometrics and hypoglycemic outcomes across an entire year

Form SD Senseonics Holdings,

Mon, 01 Jun 2026 17:08:00 -0400

si-local-file:///var/storage/secattach/20260601/26584958.html

Form SD Senseonics Holdings,

Mon, 01 Jun 2026 17:08:00 -0400

si-local-file:///var/storage/secattach/20260601/26584958.html

Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026

Mon, 01 Jun 2026 08:00:00 -0400

GERMANTOWN, Md., June 01, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable Continuous Glucose Monitoring (CGM) Systems for people with diabetes, today highlights two key company events during the 86th Scientific Sessions of the American Diabetes Association (ADA), taking place June 5-8 in New Orleans, Louisiana. Senseonics will be hosting an analyst event to discuss the Eversense 365 platform, as well as an oral presentation on the ADA program discussing real world evidence of the world’s first and only one year CGM

Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026

Mon, 01 Jun 2026 08:00:00 -0400

Form 4 Senseonics Holdings, For: May 19 Filed by: Kaufman Francine

Thu, 21 May 2026 17:43:00 -0400

si-local-file:///var/storage/secattach/20260521/26537068.html

Form 4 Senseonics Holdings, For: May 19 Filed by: Kaufman Francine

Thu, 21 May 2026 17:43:00 -0400

si-local-file:///var/storage/secattach/20260521/26537068.html

Form 4 Senseonics Holdings, For: May 19 Filed by: Horton Kenneth L

Thu, 21 May 2026 17:41:00 -0400

si-local-file:///var/storage/secattach/20260521/26537063.html

Form 4 Senseonics Holdings, For: May 19 Filed by: Horton Kenneth L

Thu, 21 May 2026 17:41:00 -0400

si-local-file:///var/storage/secattach/20260521/26537063.html

Form 4 Senseonics Holdings, For: May 19 Filed by: HANSEN BRIAN B